Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bio-Rad Laboratories, Inc. (BIO.B : NYSE)
 
 • Company Description   
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $250.08 Daily Weekly Monthly
20 Day Moving Average: 28 shares
Shares Outstanding: 27.21 (millions)
Market Capitalization: $6,805.43 (millions)
Beta: 0.81
52 Week High: $359.22
52 Week Low: $225.29
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% -5.42%
12 Week 11.00% -6.87%
Year To Date -23.19% -28.06%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1000 ALFRED NOBEL DR
-
HERCULES,CA -
USA		 ph: 510-724-7000
fax: 1-510-7415815		 investor_relations@bio-rad.com http://www.bio-rad.com
 
 • General Corporate Information   
Officers
Norman Schwartz - Chief Executive Officer and Chairman
Norman Schwartz - President and Director
Roop K. Lakkaraju - Chief Financial Officer and Executive Vice Preside
Christine A. Tsingos - Vice President;Chief Financial Officer
Jeffrey L. Edwards - Director

Peer Information
Bio-Rad Laboratories, Inc. (CORR.)
Bio-Rad Laboratories, Inc. (RSPI)
Bio-Rad Laboratories, Inc. (CGXP)
Bio-Rad Laboratories, Inc. (BGEN)
Bio-Rad Laboratories, Inc. (GTBP)
Bio-Rad Laboratories, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 090572108
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
Share - Related Items
Shares Outstanding: 27.21
Most Recent Split Date: 3.00 (2.00:1)
Beta: 0.81
Market Capitalization: $6,805.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/07/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 23.68
PEG Ratio: -
Price Ratios
Price/Book: 1.02
Price/Cash Flow: 24.06
Price / Sales: 2.68
EPS Growth
vs. Year Ago Period: 10.92%
vs. Previous Quarter: -12.41%
Sales Growth
vs. Year Ago Period: -4.16%
vs. Previous Quarter: -12.30%
ROE
06/30/25 - -
03/31/25 - 4.32
12/31/24 - 3.90
ROA
06/30/25 - -
03/31/25 - 3.03
12/31/24 - 2.76
Current Ratio
06/30/25 - -
03/31/25 - 5.99
12/31/24 - 6.48
Quick Ratio
06/30/25 - -
03/31/25 - 4.43
12/31/24 - 4.85
Operating Margin
06/30/25 - -
03/31/25 - 11.69
12/31/24 - 11.35
Net Margin
06/30/25 - -
03/31/25 - -85.16
12/31/24 - -71.86
Pre-Tax Margin
06/30/25 - -
03/31/25 - -108.23
12/31/24 - -91.27
Book Value
06/30/25 - -
03/31/25 - 245.45
12/31/24 - 234.52
Inventory Turnover
06/30/25 - -
03/31/25 - 1.50
12/31/24 - 1.51
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.18
12/31/24 - 0.18
Debt-to-Capital
06/30/25 - -
03/31/25 - 15.24
12/31/24 - 15.45
 

Powered by Zacks Investment Research ©